Efficacy and safety of dexamethasone nanoparticles eye drops in diabetic macular edema.
- Registry ID
- EUCTR2017-001172-36
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Oculis ehf.
- Start date
- 2017-06-16
- Completion date
- 2019-04-30
- Last update
- 2026-08-16
Conditions
- Diabetic macular edema
- Diabaetic macular edema
Summary
The objective of this study is to evaluate the efficacy and safety of DexNP in the improvement of visual acuity in subjects with DME.
Locations
- , , Latvia
- , , Hungary
- , , Denmark
- , , Estonia
- , , Finland
- , , Sweden
View on source registry